<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="cmt2e" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">cmt2e</book-part-id>
      <title-group>
        <title>Charcot-Marie-Tooth Neuropathy Type 2E/1F</title>
        <alt-title alt-title-type="alt-title">Synonym: CMT2E/1F</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>De Jonghe</surname>
            <given-names>Peter</given-names>
          </name>
          <xref ref-type="aff" rid="cmt2e.AFF1"/>
          <degrees>MD, PhD</degrees>
          <email>peter.dejonghe@molgen.vib-ua.be</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Jordanova</surname>
            <given-names>Albena K</given-names>
          </name>
          <xref ref-type="aff" rid="cmt2e.AFF2"/>
          <degrees>PhD</degrees>
          <email>albena.jordanova@molgen.vib-ua.be</email>
        </contrib>
      </contrib-group>
      <aff id="cmt2e.AFF1">VIB Department of Molecular Genetics<break/>University of Antwerp <break/>Antwerpen, Belgium</aff>
      <aff id="cmt2e.AFF2">VIB Department of Molecular Genetics<break/>University of Antwerp <break/>Antwerpen, Belgium</aff>
      <pub-history>
        <date iso-8601-date="2004-04-01" date-type="created">
          <day>01</day>
          <month>04</month>
          <year>2004</year>
        </date>
        <date iso-8601-date="2011-10-27" date-type="updated">
          <day>27</day>
          <month>10</month>
          <year>2011</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="cmt2a" document-type="chapter">Charcot-Marie-Tooth Neuropathy Type 2A</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="cmt4" document-type="chapter">Charcot-Marie-Tooth Neuropathy Type 4</related-object>
      <abstract id="cmt2e.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Charcot-Marie-Tooth neuropathy type 2E/1F (CMT2E/1F) is characterized by a progressive peripheral motor and sensory neuropathy with variable clinical and electrophysiologic expression. Disease onset ranges from the first to the fifth decade of life; in some cases disease onset can be in infancy. Affected individuals have difficulty walking and running because of progressive distal weakness and wasting of the muscles of the lower limbs. Paresis in the distal part of the lower limbs varies from mild weakness to a complete paralysis of the distal muscle groups. Tendon reflexes are diminished or absent. Sensory signs are not prominent but are present in all affected individuals. <italic toggle="yes">Pes cavus</italic>, hammer toes, and claw hands are frequently observed. Ambulation is generally preserved.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>In most individuals, nerve conduction velocities (NCVs) are severely to moderately reduced and fall within the CMT1 range (i.e., &#x0003c;38 m/sec for the motor median nerve), although near-normal NCVs have been described. <italic toggle="yes">NEFL,</italic> encoding the protein neurofilament light chain, is the only gene known to be associated with CMT2E/1F. </p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Affected individuals are often evaluated and managed by a multidisciplinary team that includes neurologists, physiatrists, orthopedic surgeons, and physical and occupational therapists. Treatment may include: special shoes with good ankle support, daily heel cord stretching exercises, ankle/foot orthoses, orthopedic surgery for severe <italic toggle="yes">pes cavus</italic> deformity, and crutches or canes for stability. Exercise is encouraged. Pain is treated symptomatically. </p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Daily heel cord stretching exercises to prevent Achilles' tendon shortening.</p>
          <p><italic toggle="yes">Surveillance:</italic> Monitoring gait and condition of feet to determine need for bracing, special shoes, surgery. </p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Obesity because it makes walking more difficult; drugs and medications (e.g., vincristine, isoniazid, taxol, cisplatin, nitrofurantoin) that are known to cause nerve damage.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>CMT2E/1F is usually inherited in an autosomal dominant manner; on rare occasion it can be inherited in an autosomal recessive manner. </p>
          <p><italic toggle="yes">Autosomal dominant CMT2E/1F:</italic> Most individuals with autosomal dominant CMT2E/1F have an affected parent. <italic toggle="yes">De novo</italic> mutations are more typical for individuals with a severe phenotype. The risk to sibs depends on the genetic status of the proband's parents. Each child of an individual with autosomal dominant CMT2E/1F has a 50% chance of inheriting the mutation. </p>
          <p><italic toggle="yes">Autosomal recessive CMT2E/1F:</italic> The risk to each sib of an affected individual at conception is 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. </p>
          <p>Prenatal testing for pregnancies at increased risk for both autosomal dominant and autosomal recessive CMT2E/1F is possible if the disease-causing mutation(s) in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="cmt2e.Diagnosis">
        <title>Diagnosis</title>
        <sec id="cmt2e.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Charcot-Marie-Tooth neuropathy type 2E/1F (CMT2E/1F) is suspected in individuals with a progressive peripheral motor and sensory neuropathy.</p>
          <p><bold>Nerve conduction velocities (NCVs)</bold> vary widely. In most individuals, NCVs are severely to moderately reduced and fall within the CMT1 range, i.e., less than 38 m/sec for the motor median nerve, although near-normal NCVs have also been described. The lowest reported NCV in an individual with CMT2E/1F is 12 m/sec. The amplitudes of the compound action potentials are usually severely reduced. Sensory nerve action potentials are often unrecordable. </p>
          <p><bold>Electromyogram (EMG).</bold> Concentric needle EMG shows chronic neurogenic alterations. </p>
          <p><bold>Peripheral nerve biopsy</bold> is not obligatory for diagnosis. Histopathologic studies of sural nerve biopsies showed a mixed (demyelinating and axonal) pathology, characterized by reduction mainly of large nerve fibers, thinly myelinated axons, axonal regeneration clusters, and onion bulb formation [<xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al 2003</xref>, <xref ref-type="bibr" rid="cmt2e.REF.zuchner.2004.147">Zuchner et al 2004</xref>]. Giant axons with focal accumulation of disorganized neurofilaments are also described [<xref ref-type="bibr" rid="cmt2e.REF.fabrizi.2004.1429">Fabrizi et al 2004</xref>, <xref ref-type="bibr" rid="cmt2e.REF.fabrizi.2007.394">Fabrizi et al 2007</xref>]. In an individual with autosomal recessive CMT2E/1F, a markedly reduced number of myelinated axons and only small diameter myelinated axons lacking intermediate filaments are observed [<xref ref-type="bibr" rid="cmt2e.REF.yum.2009.759">Yum et al 2009</xref>]. </p>
        </sec>
        <sec id="cmt2e.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">NEFL</italic>, encoding the protein neurofilament light chain, is the only gene in which mutations are known to cause CMT2E/1F. </p>
          <p><bold>Clinical testing</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Sequence analysis.</bold> Pathogenic variants identified to date are point mutations, small deletions, insertions, or in/dels in <italic toggle="yes">NEFL,</italic> all of which are identifiable by sequence analysis. To date, deletion or duplication of exons or of the entire gene has not been reported.</p>
            </list-item>
          </list>
          <table-wrap id="cmt2e.T.summary_of_molecular_genetic_tes" position="anchor" orientation="portrait">
            <label>Table 1.</label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Charcot-Marie-Tooth Neuropathy Type 2E/1F</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_cmt2e.T.summary_of_molecular_genetic_tes_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_b_cmt2e.T.summary_of_molecular_genetic_tes_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_b_cmt2e.T.summary_of_molecular_genetic_tes_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Mutations Detected&#x000a0;<sup>2</sup></th>
                  <th id="hd_b_cmt2e.T.summary_of_molecular_genetic_tes_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Mutation Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.summary_of_molecular_genetic_tes_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">
                    <italic toggle="yes">NEFL</italic>
                  </td>
                  <td headers="hd_b_cmt2e.T.summary_of_molecular_genetic_tes_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_b_cmt2e.T.summary_of_molecular_genetic_tes_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                  <td headers="hd_b_cmt2e.T.summary_of_molecular_genetic_tes_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">100%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="cmt2e.TF.1">
                <label>1.</label>
                <p>See <related-object source-id="gene" document-id="cmt2e" object-id="cmt2e.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. </p>
              </fn>
              <fn id="cmt2e.TF.1.1">
                <label>2.</label>
                <p>See <xref ref-type="sec" rid="cmt2e.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="cmt2e.TF.1.2">
                <label>3.</label>
                <p>The ability of the test method used to detect a mutation that is present in the indicated gene</p>
              </fn>
              <fn id="cmt2e.TF.1.3">
                <label>4.</label>
                <p>Examples of mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Interpretation of test results.</bold> Because of the presence of recessive mutations, as well as normal variants in the coding region (see <xref ref-type="table" rid="cmt2e.T.selected_nefl_allelic_variants">Table 2</xref> for examples), segregation of the mutations should be traced in the family (when possible) and normal controls should be tested. For example, <xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref> reported an individual with two <italic toggle="yes">NEFL</italic> variants p.Pro8Arg and p.Glu7Lys. Further studies demonstrated that these variants were in <italic toggle="yes">trans</italic> configuration and p.Pro8Arg was transmitted to the affected children while p.Glu7Lys was a normal variant [<xref ref-type="bibr" rid="cmt2e.REF.perezolle.2004.2207">Perez-Olle et al 2004</xref>, <xref ref-type="bibr" rid="cmt2e.REF.yamamoto.2004.75">Yamamoto et al 2004</xref>].</p>
        </sec>
        <sec id="cmt2e.Testing_Strategy">
          <title>Testing Strategy </title>
          <p><bold>To confirm/establish the diagnosis in a proband</bold> with a progressive peripheral motor and sensory neuropathy requires sequence analysis of the complete <italic toggle="yes">NEFL</italic> coding sequence. </p>
          <p><bold>Predictive testing</bold> for at-risk asymptomatic adult family members requires prior identification of the disease-causing mutation(s) in the family.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the disease-causing mutation(s) in the family.</p>
        </sec>
      </sec>
      <sec id="cmt2e.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="cmt2e.Natural_History">
          <title>Clinical Description</title>
          <p>CMT2E/1F is a progressive peripheral motor and sensory neuropathy with variable clinical and electrophysiologic expression. The disease onset is within the first five decades of life and presents with a broad clinical phenotype &#x02013; from an early-onset severe phenotype to milder forms.</p>
          <p>Some affected individuals have onset in infancy or early childhood and may display hypotonia and mildly delayed motor milestones. The presenting symptoms in most individuals are difficulties in walking and running as a result of progressive distal weakness and wasting of the lower limbs. Paresis in the distal part of the lower limbs varies from mild weakness to a complete paralysis of the distal muscle groups. In the most severely affected people, mild-to-moderate proximal arm and shoulder girdle weakness can be observed.</p>
          <p>Tendon reflexes are diminished or absent.</p>
          <p>Sensory signs are not prominent but are present in all affected individuals. </p>
          <p><italic toggle="yes">Pes cavus</italic> is the most frequently observed limb deformity, together with hammer toes and claw hands.</p>
          <p>Cerebellar dysfunction, tremor, and hearing loss are occasionally observed. </p>
          <p>Ambulation is generally preserved during life. Only one individual is reported to be wheelchair bound. </p>
          <p>Affected individuals do not have palpably enlarged nerves, ulcerated feet, or paralysis of the vocal cords and/or diaphragm.</p>
        </sec>
        <sec id="cmt2e.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>There are no obvious genotype/phenotype correlations, mainly because of the small number of reported individuals with <italic toggle="yes">NEFL</italic> mutations. However, <xref ref-type="bibr" rid="cmt2e.REF.miltenbergermiltenyi.2007.966">Miltenberger-Miltenyi et al [2007]</xref> noted that mutations in the head domain of <italic toggle="yes">NEFL</italic> may cause more severe slowing of nerve conduction velocity than mutations in the coil 2B domain. </p>
          <p>Individuals with autosomal recessive CMT2E/1F usually have more a severe phenotype, diagnosed as CMT1F.</p>
        </sec>
        <sec id="cmt2e.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is most likely to be complete.</p>
        </sec>
        <sec id="cmt2e.Anticipation">
          <title>Anticipation</title>
          <p>No clear evidence of anticipation is available in the literature.</p>
        </sec>
        <sec id="cmt2e.Nomenclature">
          <title>Nomenclature</title>
          <p>In the first reported family, NCVs were within the CMT2 range; thus this CMT variant was initially described as CMT2E [<xref ref-type="bibr" rid="cmt2e.REF.mersiyanova.2000.37">Mersiyanova et al 2000</xref>]. The subsequent observation of slow NCVs in individuals belonging to similar families and in simplex cases (i.e., those with no family history of the disorder) created a nosologic problem: OMIM classifies individuals with a CMT2 electrophysiologic phenotype as having CMT2E [<xref ref-type="bibr" rid="cmt2e.REF.mersiyanova.2000.37">Mersiyanova et al 2000</xref>], while those with a CMT1 electrophysiologic phenotype are classified as having CMT1F. </p>
          <p>CMT1F is characterized by slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, hollow feet, and reduced nerve conduction velocities (&#x0003c;38 m per sec). Onset is in early infancy or childhood and the course is usually more severe. These individuals are often diagnosed as having Dejerine-Sottas syndrome (DSS), a term that refers to this phenotype and can be observed in individuals with mutations in a number of genes; thus, the term DSS has become more confusing than helpful when considering the nosology of CMT. </p>
          <p>The reported autosomal dominant as well as autosomal recessive mode of inheritance of the disease further complicates the nosologic classification. </p>
        </sec>
        <sec id="cmt2e.Prevalence">
          <title>Prevalence</title>
          <p>The true prevalence of CMT2E/1F is not known. Preliminary data indicate that <italic toggle="yes">NEFL</italic> mutations account for 2%-5% of individuals presenting with a CMT phenotype and for about 1% of the individuals with neuropathy onset within the first year of life [<xref ref-type="bibr" rid="cmt2e.REF.baets.2011.2664">Baets et al 2011</xref>]. </p>
        </sec>
      </sec>
      <sec id="cmt2e.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>CMT2E/1F is the only disorder associated with mutations in <italic toggle="yes">NEFL</italic>. </p>
      </sec>
      <sec id="cmt2e.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The clinical and electrophysiologic phenotype of CMT2E/1F is undistinguishable from other forms of CMT/DSS (see <related-object link-type="booklink" source-id="gene" document-id="cmt" document-type="chapter">Charcot-Marie-Tooth Hereditary Neuropathy Overview</related-object>). In individuals with no family history of CMT, acquired neuropathy should also be considered. </p>
      </sec>
      <sec id="cmt2e.Management">
        <title>Management</title>
        <sec id="cmt2e.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis </title>
          <p>To establish the extent of disease in an individual diagnosed with Charcot-Marie-Tooth neuropathy type 2E/1F (CMT2E/1F), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Physical examination to determine extent of weakness and atrophy, <italic toggle="yes">pes cavus</italic>, gait stability, and sensory loss </p>
            </list-item>
            <list-item>
              <p>NCV to help distinguish demyelinating, axonal, and mixed neuropathies </p>
            </list-item>
            <list-item>
              <p>Complete family history </p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="cmt2e.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Treatment is symptomatic and affected individuals are often evaluated and managed by a multidisciplinary team that includes neurologists, physiatrists, orthopedic surgeons, and physical and occupational therapists [<xref ref-type="bibr" rid="cmt2e.REF.grandis.2005.23">Grandis &#x00026; Shy 2005</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Special shoes, including those with good ankle support, may be needed. </p>
            </list-item>
            <list-item>
              <p>Daily heel cord stretching exercises to prevent Achilles' tendon shortening are desirable. </p>
            </list-item>
            <list-item>
              <p>Affected individuals often require ankle/foot orthoses (AFO) to correct foot drop and aid walking. </p>
            </list-item>
            <list-item>
              <p>Orthopedic surgery may be required to correct severe <italic toggle="yes">pes cavus</italic> deformity [<xref ref-type="bibr" rid="cmt2e.REF.holmes.1993.476">Holmes &#x00026; Hansen 1993</xref>, <xref ref-type="bibr" rid="cmt2e.REF.guyton.2000.317">Guyton &#x00026; Mann 2000</xref>]. </p>
            </list-item>
            <list-item>
              <p>Some individuals require forearm crutches or canes for gait stability; fewer than 5% need wheelchairs. </p>
            </list-item>
            <list-item>
              <p>Exercise is encouraged within the individual's capability and many individuals remain physically active. </p>
            </list-item>
            <list-item>
              <p>Career and employment choices may be influenced by persistent weakness of hands and/or feet. </p>
            </list-item>
            <list-item>
              <p>Pain should be treated symptomatically [<xref ref-type="bibr" rid="cmt2e.REF.gemignani.2004.7">Gemignani et al 2004</xref>]. </p>
            </list-item>
          </list>
        </sec>
        <sec id="cmt2e.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>Daily heel cord stretching exercises to prevent Achilles' tendon shortening are desirable.</p>
        </sec>
        <sec id="cmt2e.Surveillance">
          <title>Surveillance </title>
          <p>Monitoring of gait and condition of feet to determine need for bracing, special shoes, surgery is appropriate. </p>
        </sec>
        <sec id="cmt2e.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Obesity is to be avoided because it makes walking more difficult. </p>
          <p>Medications that are toxic or potentially toxic to persons with CMT comprise a spectrum of risk ranging from definite high risk to negligible risk. Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="PDF File" xlink:href="cmt_and_medications.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for an up-to-date list.</p>
        </sec>
        <sec id="cmt2e.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk </title>
          <p>See <xref ref-type="sec" rid="cmt2e.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to evaluation of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="cmt2e.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="cmt2e.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="cmt2e.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Charcot-Marie-Tooth neuropathy type 2E/1F is typically inherited in an autosomal dominant manner. </p>
          <p>To date, two families with autosomal recessive CMT2E/1F (caused by homozygous nonsense mutations) have been reported [<xref ref-type="bibr" rid="cmt2e.REF.abe.2009.94">Abe et al 2009</xref>, <xref ref-type="bibr" rid="cmt2e.REF.yum.2009.759">Yum et al 2009</xref>]. </p>
        </sec>
        <sec id="cmt2e.Risk_to_Family_Members_Autosomal_D">
          <title>Risk to Family Members&#x02212;Autosomal Dominant Inheritance</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals with autosomal dominant CMT2E/1F have an affected parent. </p>
            </list-item>
            <list-item>
              <p>Occasionally, family history may be negative because the proband has a <italic toggle="yes">de novo</italic> mutation or inheritance is <xref ref-type="sec" rid="cmt2e.Risk_to_Family_Members_Autosomal_R">autosomal recessive</xref>. </p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a simplex case (i.e., an individual with no family history of the disorder) include neurologic and electrophysiologic examination and, if the mutation in the proband has been identified, molecular genetic testing. </p>
            </list-item>
          </list>
          <p>Note: Although most individuals diagnosed with autosomal dominant CMT2E/1F have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</p>
          <p><bold>Sibs of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs depends on the genetic status of the proband's parents. </p>
            </list-item>
            <list-item>
              <p>If a parent has a disease-causing autosomal dominant mutation, the risk to the sibs of inheriting the mutation is 50%. </p>
            </list-item>
            <list-item>
              <p>The presence of a <italic toggle="yes">NEFL</italic> mutation in a sib does not predict the severity of symptoms, the age of onset, or the progression of the disorder. </p>
            </list-item>
            <list-item>
              <p>If the disease-causing mutation identified in the proband cannot be detected in the leukocyte DNA of either parent, it is most likely caused by a <italic toggle="yes">de novo</italic> mutation in the proband. Another remote possibility is germline mosaicism, which has not been reported to date. </p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Each child of an individual with CMT2E/1F has a 50% chance of inheriting the mutation. </p>
            </list-item>
            <list-item>
              <p>The presence of a <italic toggle="yes">NEFL</italic> mutation in the offspring does not predict the severity of symptoms, the age of onset, or the progression of the disorder. </p>
            </list-item>
            <list-item>
              <p>Individuals who are severely affected may not reproduce. </p>
            </list-item>
          </list>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents. If a parent is affected or known to have a disease-causing mutation, his or her family members are at risk. </p>
        </sec>
        <sec id="cmt2e.Risk_to_Family_Members_Autosomal_R">
          <title>Risk to Family Members&#x02212;Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Parents of a proband with CMT2E/1F inherited in an autosomal recessive manner are obligate heterozygotes and therefore carry one mutant allele.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the chance of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The offspring of a proband with autosomal recessive CMT2E/1F are obligate heterozygotes (carriers).</p>
            </list-item>
            <list-item>
              <p>In the rare instance that an unrelated reproductive partner is a carrier, the offspring are at a 50% risk of being affected and a 50% risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>Other family members of the proband.</bold> Each sib of a proband's parents is at a 50% risk of being a carrier.</p>
          <p>
            <bold>Carrier Detection</bold>
          </p>
          <p>Carrier testing is possible once the <italic toggle="yes">NEFL</italic> mutations have been identified in the family.</p>
        </sec>
        <sec id="cmt2e.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> mutation.</bold> When neither parent of a proband with an autosomal dominant condition has the disease-causing mutation or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> mutation. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored. </p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="cmt2e.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>Prenatal diagnosis for pregnancies at increased risk is possible by analysis of DNA extracted from fetal cells obtained by chorionic villus sampling (CVS) at approximately ten to 12 weeks' gestation or amniocentesis usually performed at approximately 15 to 18 weeks' gestation. The disease-causing allele(s) of an affected family member must be identified before prenatal testing can be performed.</p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the disease-causing mutation has been identified. </p>
        </sec>
      </sec>
      <sec id="cmt2e.Resources">
        <title>Resources</title>
      </sec>
      <sec id="cmt2e.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="cmt2e.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The cytoskeleton of neuronal cells is mainly composed of three kinds of filaments: microtubules, neurofilaments, and actin filaments [<xref ref-type="bibr" rid="cmt2e.REF.tokutake.1990.1">Tokutake 1990</xref>]. Neurofilaments (NFs) belong to the family of intermediate filaments (IF) and are the most abundant component of the mature myelinated axon [<xref ref-type="bibr" rid="cmt2e.REF.friede.1970.379">Friede &#x00026; Samorajski 1970</xref>]. They have a central 310-amino acid domain (rod-domain) shaped as a large coiled-coil &#x003b1;-helix flanked by two non-helical segments: the N-terminal head and the C-terminal tail. Neurofilaments self-assemble into heteropolymers; this assembly is mediated by interactions among the rod domains of each subunit, whereas the specificity of the interactions is determined by the end domains [<xref ref-type="bibr" rid="cmt2e.REF.carpenter.1996.2493">Carpenter &#x00026; Ip 1996</xref>]. </p>
          <p>Neurofilaments in vertebrates are composed of three different protein subunits, referred to as neurofilament light chain (NEFL, 68 kd), neurofilament medium chain (NEFM, 160 kd), and neurofilament heavy chain (NEFH, 210 kd), each of these encoded by different genes [<xref ref-type="bibr" rid="cmt2e.REF.julien.1999.554">Julien 1999</xref>]. NEFL is the most abundant unit of neurofilaments and plays a central role in their assembly. It is the only NF subunit capable of self-assembling into filaments in vitro [<xref ref-type="bibr" rid="cmt2e.REF.carpenter.1996.2493">Carpenter &#x00026; Ip 1996</xref>] and also able to regulate the assembly of the other NF subunits. NEFL self-assembly is accelerated by binding to phosphatidylinositol phosphates [<xref ref-type="bibr" rid="cmt2e.REF.kim.2011.153">Kim et al 2011</xref>].</p>
          <p>Disruption of axonal transport of NFs resulting in neurofilament accumulations is a major pathologic hallmark during the early stages of many human motor neuron diseases, including <related-object link-type="booklink" source-id="gene" document-id="gan" document-type="chapter">giant axonal neuronopathy</related-object> [<xref ref-type="bibr" rid="cmt2e.REF.flanigan.1998.143">Flanigan et al 1998</xref>], <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">amyotrophic lateral sclerosis</related-object> [<xref ref-type="bibr" rid="cmt2e.REF.julien.1995.593">Julien 1995</xref>], <related-object link-type="booklink" source-id="gene" document-id="parkinson-overview" document-type="chapter">Parkinson disease</related-object> [<xref ref-type="bibr" rid="cmt2e.REF.goldman.1983.1082">Goldman et al 1983</xref>], Lewy-body-type dementia [<xref ref-type="bibr" rid="cmt2e.REF.shepherd.2002.249">Shepherd et al 2002</xref>], <related-object link-type="booklink" source-id="gene" document-id="alzheimer" document-type="chapter">Alzheimer disease</related-object> [<xref ref-type="bibr" rid="cmt2e.REF.figlewicz.1994.1757">Figlewicz et al 1994</xref>, <xref ref-type="bibr" rid="cmt2e.REF.tomkins.1998.3967">Tomkins et al 1998</xref>, <xref ref-type="bibr" rid="cmt2e.REF.alchalabi.1999.157">Al-Chalabi et al 1999</xref>], and <related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter">spinal muscular atrophy</related-object> [<xref ref-type="bibr" rid="cmt2e.REF.cifuentesdiaz.2002.1439">Cifuentes-Diaz et al 2002</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">NEFL</italic> is organized in four coding exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cmt2e" object-id="cmt2e.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Allelic variants.</bold> To date, multiple benign and pathogenic sequence variants are reported. See <xref ref-type="table" rid="cmt2e.T.selected_nefl_allelic_variants">Table 2</xref>.</p>
          <table-wrap id="cmt2e.T.selected_nefl_allelic_variants" position="anchor" orientation="portrait">
            <label>Table 2.</label>
            <caption>
              <p>Selected <italic toggle="yes">NEFL</italic> Allelic Variants </p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Class of Variant Allele</th>
                  <th id="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">References</th>
                  <th id="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_5" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_1" align="left" valign="middle" rowspan="16" colspan="1">
                    <bold>Benign</bold>
                  </td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.-42delT</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">--</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.yoshihara.2002.221">Yoshihara et al [2002]</xref>
</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_5" align="left" valign="middle" rowspan="30" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006158.3">NM_006158.3</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_006149.2">NP_006149.2</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.19G&#x0003e;A</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Glu7Lys</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.123C&#x0003e;T<break/>(120A&#x0003e;T)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.=&#x000a0;<sup>2</sup><break/>(S40S)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.192G&#x0003e;A<break/>(189G&#x0003e;A)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.=&#x000a0;<sup>2</sup><break/>(L63L)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.227T&#x0003e;C<break/>(224T&#x0003e;C)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Val76Ala<break/>(Val75Ala)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.yoshihara.2002.221">Yoshihara et al [2002]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.279G&#x0003e;A<break/>(276G&#x0003e;A)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.=&#x000a0;<sup>2</sup><break/>(Q92Q)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.yoshihara.2002.221">Yoshihara et al [2002]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.423G&#x0003e;A<break/>(420G&#x0003e;A)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.=&#x000a0;<sup>2</sup><break/>(Q140Q)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.667C&#x0003e;T<break/>(670C&#x0003e;T)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.=&#x000a0;<sup>2</sup><break/>(L224L)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.720C&#x0003e;T<break/>(723C&#x0003e;T)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.=&#x000a0;<sup>2</sup><break/>(Y241Y)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.1212C&#x0003e;T<break/>(1215C&#x0003e;T)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.=&#x000a0;<sup>2</sup><break/>(S405S)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.1326C&#x0003e;T<break/>(1329C&#x0003e;T)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.=&#x000a0;<sup>2</sup><break/>(Y443Y)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.luo.2003.169">Luo et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.1402G&#x0003e;A<break/>(1405G&#x0003e;A)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Asp468Asn<break/>(Asp469Asn)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.vechio.1996.603">Vechio et al [1996]</xref>, <xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.1458C&#x0003e;T<break/>(1461G&#x0003e;T)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.=&#x000a0;<sup>2</sup><break/>(A487A)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.1492G&#x0003e;A<break/>(1495G&#x0003e;A)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Ala498Thr<break/>(Ala499Thr)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.yoshihara.2002.221">Yoshihara et al [2002]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.1579_1581del<break/>(1582-1584delGAG)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Glu527del<break/>(Glu528del)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.yoshihara.2002.221">Yoshihara et al [2002]</xref>, <xref ref-type="bibr" rid="cmt2e.REF.yamamoto.2004.75">Yamamoto et al [2004]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.1573_1574insGAG<break/>(1576-1577insGAG)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Glu524_Glu525insGly<break/>(Glu526fs*532)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.andrigo.2005.49">Andrigo et al [2005]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_1" align="left" valign="middle" rowspan="14" colspan="1">
                    <bold>Pathogenic</bold>
                  </td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.[22C&#x0003e;A; 23C&#x0003e;G]</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Pro8Arg</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.dejonghe.2001.245">De Jonghe et al [2001]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.23C&#x0003e;G</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Pro8Arg</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.23C&#x0003e;A</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Pro8Gln</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.23C&#x0003e;T</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Pro8Leu</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.64C&#x0003e;A</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Pro22Thr</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.yoshihara.2002.221">Yoshihara et al [2002]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.64C&#x0003e;T</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Pro22Ser</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.georgiou.2002.93">Georgiou et al [2002]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.268G&#x0003e;A<break/>(265G&#x0003e;A)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Glu90Lys<break/>(Glu89Lys)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.293A&#x0003e;G<break/>(290A&#x0003e;G)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Asn98Ser<break/>(Asn97Ser)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.yoshihara.2002.221">Yoshihara et al [2002]</xref>, <xref ref-type="bibr" rid="cmt2e.REF.jordanova.2003.590">Jordanova et al [2003]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.418G&#x0003e;T&#x000a0;<sup>3</sup></td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Glu140Ter</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="cmt2e.REF.abe.2009.94">Abe et al [2009]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.446C&#x0003e;T<break/>(443C&#x0003e;T)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Ala149Val<break/>(Ala148Val)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.yoshihara.2002.221">Yoshihara et al [2002]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.628G&#x0003e;T&#x000a0;<sup>3</sup></td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Glu210Ter</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="cmt2e.REF.yum.2009.759">Yum et al [2009]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.995A&#x0003e;C<break/>(998A&#x0003e;C)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Gln332Pro<break/>(Gln333Pro)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.mersiyanova.2000.37">Mersiyanova et al [2000]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.998T&#x0003e;C<break/>(1001T&#x0003e;C)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Leu333Pro<break/>(Leu334Pro)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.choi.2004.185">Choi et al [2004]</xref>
</td>
                </tr>
                <tr>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">c.1186G&#x0003e;A<break/>(1189G&#x0003e;A)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">p.Glu396Lys<break/>(Glu397Lys)</td>
                  <td headers="hd_b_cmt2e.T.selected_nefl_allelic_variants_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="bibr" rid="cmt2e.REF.choi.2004.185">Choi et al [2004]</xref>, <xref ref-type="bibr" rid="cmt2e.REF.zuchner.2004.147">Zuchner et al [2004]</xref>
</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="cmt2e.TF.2">
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
              </fn>
              <fn id="cmt2e.TF.2.1">
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="cmt2e.TF.2.2">
                <p>1. Variant designation that does not conform to current naming conventions</p>
              </fn>
              <fn id="cmt2e.TF.2.3">
                <p>2. p. = designates that protein has not been analyzed, but no change is expected</p>
              </fn>
              <fn id="cmt2e.TF.2.4">
                <p>3. Mutations that result in autosomal recessive inheritance</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">NEFL</italic> codes for a structural protein of 543 amino acids that has head, rod, and tail domains. NEFL is a structural protein, exclusively and abundantly expressed in neurons and localized principally in axons, with higher levels in large myelinated axons. It assembles with neurofilaments of higher molecular mass, medium (NEFM) and heavy (NEFH), into intermediate filaments type IV, and forms the cytoskeleton of the neuronal cell. NEFL interacts in peripheral nerve with myotubularin-related 2 protein phosphatase (MTMR2), another CMT-associated protein mutated in CMT4B1 [<xref ref-type="bibr" rid="cmt2e.REF.previtali.2003.1713">Previtali et al 2003</xref>]. Neurofilaments are involved in radial growth and caliber maintenance of large myelinated axons and thereby play a role in their conduction velocity. </p>
          <p><bold>Abnormal gene product.</bold> In the absence of NEFL, NEFM and NEFH subunits are unable to assemble into 10-nm filaments. As a result, mice lacking NEFL protein have normal development but reduced axonal caliber and delayed maturation of regenerating myelinated axons after nerve injury. They develop mild sensorimotor dysfunction and spatial deficit without overt signs of paresis [<xref ref-type="bibr" rid="cmt2e.REF.dubois.2005.751">Dubois et al 2005</xref>]. In Japanese quail natural mutants lacking NEFL, the normal radial growth of myelinated axons is severely attenuated.</p>
          <p>The effect of dominant <italic toggle="yes">NEFL</italic> mutations described in individuals with CMT has been investigated in transgenic mammalian cells and neurons [<xref ref-type="bibr" rid="cmt2e.REF.brownlees.2002.2837">Brownlees et al 2002</xref>, <xref ref-type="bibr" rid="cmt2e.REF.perezolle.2002.4937">Perez-Olle et al 2002</xref>, <xref ref-type="bibr" rid="cmt2e.REF.perezolle.2004.2207">Perez-Olle et al 2004</xref>, <xref ref-type="bibr" rid="cmt2e.REF.perezolle.2005.861">Perez-Olle et al 2005</xref>, <xref ref-type="bibr" rid="cmt2e.REF.sasaki.2006.943">Sasaki et al 2006</xref>, <xref ref-type="bibr" rid="cmt2e.REF.zhai.2007.3103">Zhai et al 2007</xref>]. In transfected cells, dominant <italic toggle="yes">NEFL</italic> mutants disrupt both neurofilament self-assembly and co-assembly. In transfected neurons, at least some of them cause aberrant axonal transport of neurofilaments, affect the anterograde and retrograde transport of other cell components, and perturb the localization of mitochondria. This leads to progressive degeneration and loss of neuronal viability. In contrast, the recessive p.Glu210Ter mutation causes loss of NEFL protein. In affected persons homozygous for this mutation, this leads to lack of neurofilaments and progressive axonal loss [<xref ref-type="bibr" rid="cmt2e.REF.yum.2009.759">Yum et al 2009</xref>].</p>
          <p>Two transgenic mouse CMT2E models have been generated to date, expressing p.Pro22Ser and p.Glu396Lys mutations respectively [<xref ref-type="bibr" rid="cmt2e.REF.dequen.2010.2616">Dequen et al 2010</xref>, <xref ref-type="bibr" rid="cmt2e.REF.shen.2011.2535">Shen et al 2011</xref>]. Transgenic mice recapitulate the hallmark features of human pathology, including abnormal hindlimb posture, motor performance deficit, and loss of muscle innervation. Importantly, suppression of the mutant NEFL<sup>Pro22Ser</sup> product after disease onset reverses the neurologic phenotype in mice. These experiments indicate that therapeutic approaches aimed at abolishing or neutralizing the mutant <italic toggle="yes">NEFL</italic> allele could potentially halt disease progression and reverse the associated disabilities [<xref ref-type="bibr" rid="cmt2e.REF.dequen.2010.2616">Dequen et al 2010</xref>]. </p>
        </sec>
      </sec>
      <sec id="cmt2e.References">
        <title>References</title>
        <sec id="cmt2e.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="cmt2e.Literature_Cited.reflist0">
            <ref id="cmt2e.REF.abe.2009.94">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Numakura</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koide</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oka</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honma</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kishikawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayasaka</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype.</article-title>
                <source>J Hum Genet.</source>
                <year>2009</year>
                <volume>54</volume>
                <fpage>94</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19158810</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.alchalabi.1999.157">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Chalabi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersen</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nilsson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chioza</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russ</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leigh</surname>
                    <given-names>PN</given-names>
                  </name>
                </person-group>
                <article-title>Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis.</article-title>
                <source>Hum Mol Genet</source>
                <year>1999</year>
                <volume>8</volume>
                <fpage>157</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">9931323</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.andrigo.2005.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Andrigo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boito</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prandini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mostacciuolo</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siciliano</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pegoraro</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>A novel out-of-frame mutation in the neurofilament light chain gene (NEFL) does not result in Charcot-Marie-Tooth disease type 2E.</article-title>
                <source>Neurogenetics</source>
                <year>2005</year>
                <volume>6</volume>
                <fpage>49</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">15654615</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.baets.2011.2664">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baets</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deconinck</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vriendt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimo&#x00144;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yperzeele</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hoorenbeeck</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peeters</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spiegel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parman</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceulemans</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Bogaert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pou-Serradell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernert</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinopoulos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auer-Grumbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sallinen</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fabrizi</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pauly</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van den Bergh</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bilir</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battaloglu</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madrid</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabzi&#x00144;ska</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kochanski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topaloglu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jordanova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Genetic spectrum of hereditary neuropathies with onset in the first year of life.</article-title>
                <source>Brain.</source>
                <year>2011</year>
                <volume>134</volume>
                <fpage>2664</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">21840889</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.brownlees.2002.2837">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brownlees</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerley</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grierson</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobsen</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shea</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderton</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leigh</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>CC</given-names>
                  </name>
                </person-group>
                <article-title>Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport.</article-title>
                <source>Hum Mol Genet</source>
                <year>2002</year>
                <volume>11</volume>
                <fpage>2837</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">12393795</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.carpenter.1996.2493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ip</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Neurofilament triplet protein interactions: evidence for the preferred formation of NF-L-containing dimers and a putative function for the end domains.</article-title>
                <source>J Cell Sci</source>
                <year>1996</year>
                <volume>109</volume>
                <fpage>2493</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8923210</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.choi.2004.185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>BO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sunwoo</surname>
                    <given-names>IN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>KW</given-names>
                  </name>
                </person-group>
                <article-title>Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients.</article-title>
                <source>Hum Mutat</source>
                <year>2004</year>
                <volume>24</volume>
                <fpage>185</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15241803</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.cifuentesdiaz.2002.1439">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cifuentes-Diaz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicole</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velasco</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borra-Cebrian</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panozzo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frugier</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Millet</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roblot</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joshi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melki</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model.</article-title>
                <source>Hum Mol Genet</source>
                <year>2002</year>
                <volume>11</volume>
                <fpage>1439</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">12023986</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.dejonghe.2001.245">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mersivanova</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Favero</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evgrafov</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E.</article-title>
                <source>Ann Neurol</source>
                <year>2001</year>
                <volume>49</volume>
                <fpage>245</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11220745</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.dequen.2010.2616">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dequen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larivi&#x000e8;re</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perrot</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hisanaga</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julien</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Reversal of neuropathy phenotypes in conditional mouse model of Charcot-Marie-Tooth disease type 2E.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2010</year>
                <volume>19</volume>
                <fpage>2616</fpage>
                <lpage>29</lpage>
                <pub-id pub-id-type="pmid">20421365</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.dubois.2005.751">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dubois</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strazielle</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julien</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalonde</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Mice with the deleted neurofilament of low molecular weight (Nefl) gene: 2. Effects on motor functions and spatial orientation.</article-title>
                <source>J Neurosci Res</source>
                <year>2005</year>
                <volume>80</volume>
                <fpage>751</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15884021</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.fabrizi.2004.1429">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fabrizi</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavallaro</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angiari</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertolasi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabrini</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrarini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzuto</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E.</article-title>
                <source>Neurology</source>
                <year>2004</year>
                <volume>62</volume>
                <fpage>1429</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">15111691</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.fabrizi.2007.394">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fabrizi</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavallaro</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angiari</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabrini</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taioli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malerba</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertolasi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzuto</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton.</article-title>
                <source>Brain.</source>
                <year>2007</year>
                <volume>130</volume>
                <fpage>394</fpage>
                <lpage>403</lpage>
                <pub-id pub-id-type="pmid">17052987</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.figlewicz.1994.1757">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Figlewicz</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krizus</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinoli</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meininger</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julien</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis.</article-title>
                <source>Hum Mol Genet</source>
                <year>1994</year>
                <volume>3</volume>
                <fpage>1757</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">7849698</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.flanigan.1998.143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flanigan</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crawford</surname>
                    <given-names>TO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlschutter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ranells</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camfield</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ptacek</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <article-title>Localization of the giant axonal neuropathy gene to chromosome 16q24.</article-title>
                <source>Ann Neurol</source>
                <year>1998</year>
                <volume>43</volume>
                <fpage>143</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9450783</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.friede.1970.379">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Friede</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samorajski</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice.</article-title>
                <source>Anat Rec</source>
                <year>1970</year>
                <volume>167</volume>
                <fpage>379</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">5454590</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.gemignani.2004.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gemignani</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alfieri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglese</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marbini</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Sensory manifestations in Charcot-Marie-Tooth disease.</article-title>
                <source>J Peripher Nerv Syst</source>
                <year>2004</year>
                <volume>9</volume>
                <fpage>7</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">14871449</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.georgiou.2002.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Georgiou</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zidar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korosec</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Middleton</surname>
                    <given-names>LT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kyriakides</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christodoulou</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family.</article-title>
                <source>Neurogenetics</source>
                <year>2002</year>
                <volume>4</volume>
                <fpage>93</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12481988</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.goldman.1983.1082">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldman</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yen</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiu</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peress</surname>
                    <given-names>NS</given-names>
                  </name>
                </person-group>
                <article-title>Lewy bodies of Parkinson's disease contain neurofilament antigens.</article-title>
                <source>Science</source>
                <year>1983</year>
                <volume>221</volume>
                <fpage>1082</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">6308771</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.grandis.2005.23">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grandis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shy</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <article-title>Current Therapy for Charcot-Marie-Tooth Disease.</article-title>
                <source>Curr Treat Options Neurol</source>
                <year>2005</year>
                <volume>7</volume>
                <fpage>23</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">15610704</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.guyton.2000.317">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guyton</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mann</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <article-title>The pathogenesis and surgical management of foot deformity in Charcot-Marie-Tooth disease.</article-title>
                <source>Foot Ankle Clin</source>
                <year>2000</year>
                <volume>5</volume>
                <fpage>317</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">11232233</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.holmes.1993.476">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holmes</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>ST</given-names>
                  </name>
                </person-group>
                <article-title>Foot and ankle manifestations of Charcot-Marie-Tooth disease.</article-title>
                <source>Foot Ankle</source>
                <year>1993</year>
                <volume>14</volume>
                <fpage>476</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">8253442</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.jordanova.2003.590">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jordanova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boerkoel</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takashima</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vriendt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceuterick</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancias</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papasozomenos</surname>
                    <given-names>SCh</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terespolsky</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potocki</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rita</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournev</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremensky</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease.</article-title>
                <source>Brain</source>
                <year>2003</year>
                <volume>126</volume>
                <fpage>590</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12566280</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.julien.1995.593">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Julien</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>A role for neurofilaments in the pathogenesis of amyotrophic lateral sclerosis.</article-title>
                <source>Biochem Cell Biol</source>
                <year>1995</year>
                <volume>73</volume>
                <fpage>593</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8714677</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.julien.1999.554">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Julien</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Neurofilament functions in health and disease.</article-title>
                <source>Curr Opin Neurobiol</source>
                <year>1999</year>
                <volume>9</volume>
                <fpage>554</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">10508735</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.kim.2011.153">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>YR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suh</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <article-title>Phosphatidylinositol phosphates directly bind to neurofilament light chain (NF-L) for the regulation of NF-L self assembly.</article-title>
                <source>Exp Mol Med.</source>
                <year>2011</year>
                <volume>43</volume>
                <fpage>153</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">21339697</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.luo.2003.169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <source>Zhonghua Yi Xue Yi Chuan Xue Za Zhi</source>
                <year>2003</year>
                <volume>20</volume>
                <fpage>169</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">12673592</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.mersiyanova.2000.37">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mersiyanova</surname>
                    <given-names>IV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perepelov</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polyakov</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sitnikov</surname>
                    <given-names>VF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dadali</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oparin</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrin</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evgrafov</surname>
                    <given-names>OV</given-names>
                  </name>
                </person-group>
                <article-title>A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.</article-title>
                <source>Am J Hum Genet</source>
                <year>2000</year>
                <volume>67</volume>
                <fpage>37</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">10841809</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.miltenbergermiltenyi.2007.966">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miltenberger-Miltenyi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janecke</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wanschitz</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Windpassinger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auer-Grumbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;scher</surname>
                    <given-names>WN</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.</article-title>
                <source>Arch Neurol.</source>
                <year>2007</year>
                <volume>64</volume>
                <fpage>966</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">17620486</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.perezolle.2004.2207">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perez-Olle</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liem</surname>
                    <given-names>RK</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models.</article-title>
                <source>Hum Mol Genet</source>
                <year>2004</year>
                <volume>13</volume>
                <fpage>2207</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">15282209</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.perezolle.2002.4937">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perez-Olle</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leung</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liem</surname>
                    <given-names>RK</given-names>
                  </name>
                </person-group>
                <article-title>Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation.</article-title>
                <source>J Cell Sci</source>
                <year>2002</year>
                <volume>115</volume>
                <fpage>4937</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">12432080</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.perezolle.2005.861">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perez-Olle</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez-Toledano</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goryunov</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabrera-Poch</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanis</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liem</surname>
                    <given-names>RK</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport.</article-title>
                <source>J Neurochem</source>
                <year>2005</year>
                <volume>93</volume>
                <fpage>861</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">15857389</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.previtali.2003.1713">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Previtali</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerega</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherman</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brophy</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dina</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feltri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quattrini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravazzolo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wrabetz</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolino</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve.</article-title>
                <source>Hum Mol Genet</source>
                <year>2003</year>
                <volume>12</volume>
                <fpage>1713</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">12837694</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.sasaki.2006.943">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gotow</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiozaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakaue</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julien</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchiyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hisanaga</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot-Marie-Tooth disease mutants.</article-title>
                <source>Hum Mol Genet</source>
                <year>2006</year>
                <volume>15</volume>
                <fpage>943</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">16452125</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.shen.2011.2535">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barry</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dale</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>VB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calcutt</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <article-title>Muscle pathology without severe nerve pathology in a new mouse model of Charcot-Marie-Tooth disease type 2E.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2011</year>
                <volume>20</volume>
                <fpage>2535</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">21493625</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.shepherd.2002.249">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shepherd</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCann</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halliday</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <article-title>Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.</article-title>
                <source>Neurobiol Dis</source>
                <year>2002</year>
                <volume>9</volume>
                <fpage>249</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">11895376</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.tokutake.1990.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tokutake</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>On the assembly mechanism of neurofilaments.</article-title>
                <source>Int J Biochem</source>
                <year>1990</year>
                <volume>22</volume>
                <fpage>1</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">2184054</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.tomkins.1998.3967">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tomkins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Usher</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slade</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ince</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curtis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <article-title>Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS).</article-title>
                <source>Neuroreport</source>
                <year>1998</year>
                <volume>9</volume>
                <fpage>3967</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">9875737</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.vechio.1996.603">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vechio</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruijn</surname>
                    <given-names>LI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cleveland</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <article-title>Sequence variants in human neurofilament proteins: absence of linkage to familial amyotrophic lateral sclerosis.</article-title>
                <source>Ann Neurol</source>
                <year>1996</year>
                <volume>40</volume>
                <fpage>603</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">8871580</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.yamamoto.2004.75">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshihara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattori</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Glu528del in NEFL is a polymorphic variant rather than a disease-causing mutation for Charcot-Marie-Tooth disease in Japan.</article-title>
                <source>Neurogenetics</source>
                <year>2004</year>
                <volume>5</volume>
                <fpage>75</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">14586770</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.yoshihara.2002.221">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yoshihara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattori</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Misu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koike</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Identification of novel sequence variants in the neurofilament-light gene in a Japanese population: analysis of Charcot-Marie-Tooth disease patients and normal individuals.</article-title>
                <source>J Peripher Nerv Syst</source>
                <year>2002</year>
                <volume>7</volume>
                <fpage>221</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12477167</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.yum.2009.759">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yum</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>SS</given-names>
                  </name>
                </person-group>
                <article-title>A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy.</article-title>
                <source>Ann Neurol.</source>
                <year>2009</year>
                <volume>66</volume>
                <fpage>759</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">20039262</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.zhai.2007.3103">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhai</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julien</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlaepfer</surname>
                    <given-names>WW</given-names>
                  </name>
                </person-group>
                <article-title>Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth disease-linked mutations in NFL and HSPB1.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2007</year>
                <volume>16</volume>
                <fpage>3103</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">17881652</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.zuchner.2004.147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zuchner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vorgerd</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sindern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroder</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy.</article-title>
                <source>Neuromuscul Disord</source>
                <year>2004</year>
                <volume>14</volume>
                <fpage>147</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">14733962</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="cmt2e.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="cmt2e.Suggested_Reading.reflist0">
            <ref id="cmt2e.REF.carter.1997.69">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>GT</given-names>
                  </name>
                </person-group>
                <article-title>Rehabilitation management in neuromuscular disease.</article-title>
                <source>J Neurol Rehab</source>
                <year>1997</year>
                <volume>11</volume>
                <fpage>69</fpage>
                <lpage>80</lpage>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.chaudhry.2003.337">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chaudhry</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaudhry</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crawford</surname>
                    <given-names>TO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simmons-O'Brien</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>JW</given-names>
                  </name>
                </person-group>
                <article-title>Toxic neuropathy in patients with pre-existing neuropathy.</article-title>
                <source>Neurology</source>
                <year>2003</year>
                <volume>60</volume>
                <fpage>337</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">12552058</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.lee.1994.975">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marszalek</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cleveland</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <article-title>A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease.</article-title>
                <source>Neuron</source>
                <year>1994</year>
                <volume>13</volume>
                <fpage>975</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">7946341</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.nelis.1999.11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nelis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haites</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies.</article-title>
                <source>Hum Mutat</source>
                <year>1999</year>
                <volume>13</volume>
                <fpage>11</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">9888385</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.ohara.1993.387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohara</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gahara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teraoka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitamura</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene.</article-title>
                <source>J Cell Biol</source>
                <year>1993</year>
                <volume>121</volume>
                <fpage>387</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">8468353</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.xu.1993.23">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cork</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cleveland</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <article-title>Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease.</article-title>
                <source>Cell</source>
                <year>1993</year>
                <volume>73</volume>
                <fpage>23</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">8462100</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.yamasaki.1992.734">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamasaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itakura</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizutani</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Defective expression of neurofilament protein subunits in hereditary hypotrophic axonopathy of quail.</article-title>
                <source>Lab Invest</source>
                <year>1992</year>
                <volume>66</volume>
                <fpage>734</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">1602743</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt2e.REF.zhu.1997.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couillard-Despres</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julien</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments.</article-title>
                <source>Exp Neurol</source>
                <year>1997</year>
                <volume>148</volume>
                <fpage>299</fpage>
                <lpage>316</lpage>
                <pub-id pub-id-type="pmid">9398473</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="cmt2e.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="cmt2e.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>27 October 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>15 June 2006 (ca) Comprehensive update posted to live Web site </p>
            </list-item>
            <list-item>
              <p>1 April 2004 (me) Review posted to live Web site </p>
            </list-item>
            <list-item>
              <p>6 October 2003 (pdj) Original submission </p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
